The success of the anti-glaucoma drug development pipeline depends on the success of basic and preclinical studies. In preclinical trials, we can perform in vivo studies in animal subjects. In vivo studies can demonstrate the effectiveness and safety of the drug on the body. Rodents, primates, rabbits, dogs, etc. are often used in preclinical in vivo studies and they often have the advantage of similar eye structure to humans and ease of handling.

With our specialized preclinical services and various ophthalmic technology platforms, Ace Ophthalmology offers clients a one-stop shop for preclinical in vivo studies, including the development of a range of animal models of glaucoma, evaluation of drug efficacy, safety, possible mechanisms of action, pharmacokinetic and pharmacodynamic properties. We are committed to efficiently conducting preclinical evaluations of new anti-glaucoma drugs to help guide drug development decisions and clinical trial design.

Learn more：ocular tolerability services